Psychotropic and other medicine use at time of death by suicide: a population‐level analysis of linked dispensing and forensic toxicology data
Open Access
- 25 May 2023
- journal article
- research article
- Published by Wiley in The Medical Journal of Australia
- Vol. 219 (2), 63-69
- https://doi.org/10.5694/mja2.51985
Abstract
To determine the numbers and types of medicines dispensed around the time of death to people who die by suicide; to compare the medicines recently dispensed and those recorded in post mortem toxicology reports. Analysis of linked National Coronial Information System (NCIS) and Pharmaceutical Benefits Scheme (PBS) data from the Australian Suicide Prevention using Health Linked Data (ASHLi) study, a population‐based case series study of closed coronial cases for deaths of people in Australia aged ten years or more during 1 July 2013 – 10 October 2019 deemed by coroners to be the result of intentional self‐harm. Proportions of people to whom medicines were dispensed around the time of death, by medicine group, class, and specific medicine; comparison of medicines recently dispensed and those detected by post mortem toxicology. Toxicology reports were available for 13 541 of 14 206 people who died by suicide (95.3%; 10 246 men, 75.7%); poisoning with medicines contributed to 1163 deaths (8.6%). At least one PBS‐subsidised medicine had been dispensed around the time of death to 7998 people (59.1%). For three medicine classes, the proportions of people in whom the medicines were detected post mortem and their death was deemed medicine‐related were larger for those without records of recent dispensing than for people for whom they had been dispensed around the time of death: antidepressants (17.7% v 12.0%), anxiolytics (16.3% v 14.8%), and sedatives/hypnotics (24.3% v 16.5%). At least one recently dispensed medicine not detected post mortem was identified for 6208 people (45.8%). A considerable proportion of people who died by suicide were not taking psychotropic medicines recently dispensed to them, suggesting non‐adherence to pharmacotherapy, and a smaller than expected proportion were using antidepressants. Conversely, medicines that had not recently been dispensed were detected post mortem in many people for whom poisoning with medicines was a contributing factor, suggesting medicine stockpiling.Keywords
Funding Information
- Cancer Institute NSW (ECF1381)
- National Health and Medical Research Council (1122362, 1157757, 1158763, 1196516, 196900)
This publication has 24 references indexed in Scilit:
- Association of Isotretinoin With Depression and Suicide: A Review of Current LiteratureJournal of Cutaneous Medicine and Surgery, 2017
- Major Physical Health Conditions and Risk of SuicideAmerican Journal of Preventive Medicine, 2017
- Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization’s adverse drug reactions database and discussion of potential mechanismsPsychopharmacology, 2016
- The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchersBMC Research Notes, 2015
- Interpreting postmortem drug analysis and redistribution in determining cause of death: a reviewPathology and Laboratory Medicine International, 2015
- The Burden Attributable to Mental and Substance Use Disorders as Risk Factors for Suicide: Findings from the Global Burden of Disease Study 2010PLOS ONE, 2014
- Interpretation of postmortem forensic toxicology results for injury prevention researchInjury Prevention, 2012
- Substances Used in Completed Suicide by Overdose in Toronto: An Observational Study of Coroner's DataThe Canadian Journal of Psychiatry, 2012
- Assessment of the stability of 30 antipsychotic drugs in stored blood specimensForensic Science International, 2012
- Antidepressant Discontinuation and Risk of Suicide AttemptBritish Journal of Psychology, 2009